跳至主要内容
临床试验/NCT02857192
NCT02857192已完成不适用

Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Giant Cell Arteritis (Horton's Disease)

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2015年10月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
1
主要终点
Measurement by flow cytometry of the percentage of CD39+ Treg (CD4+CD25highFoxP3+CD39+) among total CD4 TL

研究概览

简要总结

Giant cell arteritis (GCA) is the most frequent vascularitis after 50 years of age The investigators recently showed that GCA was accompanied by an elevation in Th1 and Th17 response [1]. Even though a quantitative deficit in regulatory TL (Treg) was shown, there are to date no data concerning their precise phenotypic and functional characteristics and notably their ability to inhibit Th1 and Th17 polarisation. The hypothesis of the investigator is that, in GCA, there is quantitative and above all functional deficit of Treg. Recently, progress has been made in the identification of Treg with new markers (CD39), which will make it possible to better identify and to study their specific functions. In this study the phenotypic and functional characteristics of Treg in GCA will be analysed. Better understanding of the role des Treg in GCA should lead to better-targeted treatments for patients with GCA, notably via the blockage of cytokines that inhibit the differentiation and/or function of Treg.

The study is classified interventional because a lot of blood samples are taken.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
51 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have provided written consent
  • Patients with national health insurance cover
  • Age > 50 years
  • Patients with a diagnosis of Horton's disease, before any treatment
  • Horton's disease is defined by the American College Rheumatology ACR criteria [2], as the association of 3 of the following 5 criteria:
  • age at disease onset 50 years or older
  • recent onset localized headache
  • indurated temporal artery or diminished/abolition of temporal pulse
  • erythrocyte sedimentation rate (ESR) greater than 50 mm during the first hour (or C Reactive protein (CRP)>20 mg/L)
  • Positive temporal artery biopsy (TAB) showing vascularitis with infiltration by mononuclear cells or granulomatous inflammation with or without giant cells.
  • Control subjects
  • Control subjects will be healthy volunteers recruited among blood donors at Dijon University Hospital, voluntary hospital personnel (nurses, doctors, laboratory technicians and secretaries) and patients without infectious, inflammatory or auto-immune diseases or cancer (CRP<5mg/L) recruited in the investigating departments of Dijon Hospital. They will be matched for age and sex and must meet the following criteria:
  • Age > 50 years
  • Patients with national health insurance cover
  • Signed written informed consent form
  • Absence of an inflammatory syndrome (CRP<5 mg /L)

排除标准

  • Adult under guardianship
  • Persons without national health insurance cover
  • Pregnant or breast-feeding women
  • Patients treated with corticoids or immunosuppressants in the month preceding inclusion
  • Patients treated with chemotherapy

研究组 & 干预措施

Horton

Experimental

干预措施: Blood samples (Biological)

control

Placebo Comparator

干预措施: Blood samples (Biological)

结局指标

主要结局

Measurement by flow cytometry of the percentage of CD39+ Treg (CD4+CD25highFoxP3+CD39+) among total CD4 TL

时间窗: through study completion an average of 30 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验